Market Place
Sourcing Support
Curatis Plans Biologic License Application for C-PTBE-01 in USA
14 Nov 2024 //
BUSINESSWIRE
Curatis Reports Increased Sales And On-Track Development Projects
16 Sep 2024 //
BUSINESSWIRE
Curatis On Track For US Orphan Drug Designation Application
27 Aug 2024 //
BUSINESSWIRE
Curatis Holding AG publishes Annual Report of the Kinarus Group for FY2023
24 May 2024 //
PHARMIWEB
Kinarus Therapeutics Announces Personnel Change
12 Jul 2023 //
GLOBENEWSWIRE
Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting
02 Jun 2023 //
GLOBENEWSWIRE
Kinarus Therapeutics signed CHF1.5M convertible loan agreement with ChaoDian
10 May 2023 //
GLOBENEWSWIRE
Kinarus receives deadline extension from SER for publication of financial report
28 Apr 2023 //
GLOBENEWSWIRE
Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical Trial Progress Update
21 Feb 2023 //
GLOBENEWSWIRE
Kinarus Reports Preclinical Data in Lung Fibrosis and Discloses Development Plan
17 Jan 2023 //
GLOBENEWSWIRE
Kinarus Receives USPTO Notice of Allowance for Lead Therapeutic Candidate KIN001
21 Nov 2022 //
GLOBENEWSWIRE
Kinarus to explore partnership in China to fund phase 2 trials of KIN001
18 Nov 2022 //
PHARMABIZ
Kinarus Engages Great Health Companion Group to Explore Partnerships in China
16 Nov 2022 //
GLOBENEWSWIRE
Kinarus doses first subject in Phase II Covid-19 drug combination trial
30 Aug 2022 //
CLINICALTRIALSARENA
Kinarus Therapeutics Reports H1 2022 Financial Results & Provides Update
30 Aug 2022 //
GLOBENEWSWIRE
Kinarus Therapeutics initiates KIN001 Ph II KINFAST clinical trial in COVID-19
29 Aug 2022 //
GLOBENEWSWIRE
Kinarus Therapeutics to hold webinar on a new approach to treating COVID-19
22 Aug 2022 //
GLOBENEWSWIRE
Kinarus Therapeutics to host KOL event for KIN001
23 Jun 2022 //
BUSINESSWIRE
Kinarus Tx’ KIN001 Shows Strong Antiviral Activity
20 Jun 2022 //
BUSINESSWIRE
Positive Preclinical Data Lead Compound KIN001 in COVID-19
23 Aug 2021 //
BIOSPACE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.